Blood Tests for Inflammation: CRP, ESR, and What Elevated Markers May Indicate

Why Inflammation Shows Up in Blood Tests

Acute inflammation is the body's protective response to infection or injury. Chronic, low-grade inflammation is different—it smolders silently and has been linked to cardiovascular disease, type 2 diabetes, and several autoimmune conditions.[1] Because chronic inflammation produces no obvious symptoms in its early stages, blood tests are often the only way to detect it. Four markers are most commonly used in clinical practice: C-reactive protein (CRP), high-sensitivity CRP (hs-CRP), erythrocyte sedimentation rate (ESR), and homocysteine.

C-Reactive Protein (CRP)

CRP is a protein produced by the liver in response to inflammatory signals, particularly the cytokine interleukin-6. It rises within hours of an inflammatory stimulus and falls quickly once the trigger resolves, making it one of the most responsive acute-phase reactants.[3] Standard CRP is most useful for detecting or monitoring acute infections, autoimmune flares, or post-surgical inflammation.

Normal CRP is typically below 10 mg/L, though many laboratories report the upper limit of normal as 8 mg/L. Values above 100 mg/L strongly suggest a bacterial infection or major tissue injury. Values in the range of 10–100 mg/L are less specific and may reflect viral illness, inflammatory bowel disease, or rheumatoid arthritis. A CRP within normal limits does not rule out low-grade chronic inflammation—that is where hs-CRP becomes important.

High-Sensitivity CRP (hs-CRP)

High-sensitivity CRP uses a more precise assay than standard CRP, capable of detecting concentrations as low as 0.3 mg/L. This sensitivity makes hs-CRP the preferred marker for cardiovascular risk stratification rather than for diagnosing acute illness. The American Heart Association and Centers for Disease Control and Prevention classify hs-CRP risk as follows: below 1.0 mg/L is low risk, 1.0–3.0 mg/L is average risk, and above 3.0 mg/L is high risk for future cardiovascular events.[2]

The landmark JUPITER trial demonstrated that statin therapy reduced cardiovascular events in patients with elevated hs-CRP even when LDL cholesterol was within the normal range, highlighting the independent predictive value of this marker. hs-CRP should be measured on two separate occasions at least two weeks apart to avoid capturing transient spikes caused by minor illness or vigorous exercise.

Erythrocyte Sedimentation Rate (ESR)

ESR measures how quickly red blood cells settle to the bottom of a test tube over one hour. Inflammation causes proteins such as fibrinogen to coat red blood cells and promote clumping, which accelerates sedimentation.[4] The result is expressed in millimeters per hour (mm/hr). Normal ESR is generally 0–20 mm/hr for men and 0–30 mm/hr for women, with values rising modestly with age.

ESR is less specific than CRP—it responds more slowly to changes in inflammation and is affected by anemia, pregnancy, and kidney disease, all of which can elevate it independently of true inflammation. However, a markedly elevated ESR (above 100 mm/hr) is clinically significant and raises concern for conditions such as giant cell arteritis, multiple myeloma, or sepsis. In rheumatology, ESR and CRP are frequently ordered together because they sometimes diverge: ESR can remain elevated long after CRP normalizes, making it useful for monitoring disease activity over weeks rather than days.

Homocysteine

Homocysteine is an amino acid produced during the metabolism of methionine. Elevated homocysteine—a state called hyperhomocysteinemia—promotes endothelial dysfunction and oxidative stress, mechanisms that overlap with inflammatory pathways. Normal fasting homocysteine is generally 5–15 µmol/L. Levels above 15 µmol/L are considered elevated, and levels above 30 µmol/L are classified as severely high.

Deficiencies in folate, vitamin B6, and vitamin B12 are the most common reversible causes of elevated homocysteine, because these nutrients are required for the enzymatic pathways that clear homocysteine from the blood. Chronic kidney disease and hypothyroidism also raise homocysteine. Supplementing with B vitamins reliably lowers homocysteine levels, though clinical trial results on whether this translates into reduced cardiovascular events have been mixed. For a detailed breakdown of this biomarker, see the Health3 homocysteine biomarker page.

Using These Markers Together

No single inflammation marker tells the complete story. CRP and hs-CRP respond quickly and are highly sensitive to acute changes, while ESR changes more slowly and may reflect prolonged inflammatory states. Homocysteine adds a metabolic and vascular dimension that the other markers miss. Clinicians often interpret these tests alongside a lipid panel, CBC, and metabolic panel to build a full picture of inflammatory and cardiovascular risk.[1]

Lifestyle interventions—regular aerobic exercise, a diet rich in omega-3 fatty acids and antioxidants, smoking cessation, and weight management—have all been shown to reduce CRP, ESR, and homocysteine. Tracking these markers over time with a health monitoring app allows you to see whether lifestyle changes are measurably reducing your inflammatory burden.

Track Your Biomarkers With Health3

Scan your lab results, explore biomarker interactions, and track trends over time with the Health3 app.